Our innovative study, the biggest of its kind ever conducted in this area of medicine in the UK, aimed to identify the best way to look after patients arriving in hospital with Small Bowel Obstruction. This is the first and most important step to setting NHS guidelines for their care.
Designed, led & implemented by surgical Trainees, NASBO is a revolutionary research project that is now garnering attention throughout the UK and beyond
Rectal prolapse is a distressing condition where the bowel lining prolapses outside the anal canal.
Only surgery can cure the problem and surgeons have invented many operations to do this.
It is common in children, usually before the age of four. It affects girls and boys equally. Adults can also develop rectal prolapse, especially women over 60.
RAPPORT (RectAl ProlaPse OpeRation Trial) is being developed to try and work out the best operation for rectal prolapse.
Recovery after surgery on the bowel
a placebo-controlled rAndomised trial of intravenous Liodocaine in acceLErating Gastrointestinal Recovery after cOlorectal surgery
A trial gaining insight to ileus – Ileus is the medical term for this lack of movement somewhere in the intestines that leads to a buildup and potential blockage of food material. An ileus can lead to an intestinal obstruction. This means no food material, gas, or liquids can get through. It can occur as a side effect after surgery.
Elective colorectal surgery is a common NHS hospital intervention (approx. 30,000 operations per year), following which delayed return of gut function is the most common cause of delayed discharge from hospital. A reduction in the current 20-40% prevalence would benefit a large number of patients with attendant reduction in health service costs related to reduced length of stay and reduced expenditure on management of the complication itself. Intravenous lidocaine is cheap, safe and easy to administer, and offers to reduce prevalence of delayed return of gut function and accelerate postoperative recovery
This trial was initiated through the Delphi Exercise and has now gone on to receive a £1million funding grant from the NIHR
Cohort study to Investigate the prevention of Parastomal HERnia
CIPHER’s primary outcome is identification of a symptomatic parastomal hernia. Symptoms drive care seeking behaviour by patients and clinical intervention by surgeons.
Yet another one of the projects to have been curated through the Delphi Exercise
This is now a major trial that has been granted £1million by the NIHR to further this work and is looking to recruit 4,000 patients and is s co-ordinated by the Clinical Trials Unit at Bristol University, in conjunction with three consultant colorectal surgeons from Royal Devon & Exeter Hospital and QE Hospital Birmingham.